ArticleOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2026
Retrospective Comparative Analysis of Myopia Control Efficacy: Orthokeratology, Defocus-Incorporated Soft Contact Lenses and Their Combination with 0.01% Atropine in Chinese Children and Adolescents.
Article in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeTo evaluate the efficacies of orthokeratology (OK), defocus-incorporated soft contact lenses (DISC) and their combination with 0.01% atropine in slowing myopia progression in Chinese children and adolescents.
methodsThis retrospective study analysed 336 myopic participants aged 6-15 years, including 144 males (42.9%) and 192 females (57.1%). The participants were divided into 4 groups: OK (n = 89), OK combined with 0.01% atropine (OKA, n = 84), DISC (n = 82) and DISC combined with 0.01% atropine (DISCA, n = 81). Axial length (AL) was measured at baseline and after 3, 6, 9 and 12 months. Differences in AL changes among the groups were compared and subgroup analyses were conducted based on the initial age and spherical equivalent to explore the effectiveness of interventions across age and refractive error.
resultsAfter 12 months, OKA had less axial elongation than OK (-0.08, 95% CI [-0.11, -0.05]), DISC (-0.07, 95% CI [-0.10, -0.04]) and DISCA (-0.06, 95% CI [-0.10, -0.04]). Subgroup analyses revealed significant differences between the OK and OKA groups at three follow-up time points in the aged 6-9 year (0.04, 95% CI [0.003, 0.08], 0.05, 95% CI [0.008, 0.09], 0.08, 95% CI [0.04, 0.12]) and 0 to -2.75 dioptre (D) subgroups (0.04, 95% CI [0.001, 0.08], 0.06, 95% CI [0.02, 0.09], 0.10, 95% CI [0.06, 0.13]), with significant differences being observed at 12 months in the aged 10-15 year (0.07, 95% CI [0.01, 0.13]) and -3.00 to -6.00 D subgroups (0.08, 95% CI [0.01, 0.14]). Significant differences between OK and DISC were limited to the 0 to -2.75D subgroup at 3 months (0.05, 95% CI [0.009, 0.09]) and 12 months (0.04, 95% CI [0.001, 0.08]).
conclusionOKA demonstrated superior myopia control efficacy than OK, DISC and DISCA. The synergistic effect of 0.01% atropine combined with OK was more pronounced in younger age and low myopia subgroups. Notably, DISC showed significantly better efficacy than OK in children with low myopia.
Indexed as
Identifiers
42098575What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.